Carl Zeiss Meditec Invests in Sales Expansion in Spain
(Thomson Reuters ONE) -
Carl Zeiss Meditec AG /
Carl Zeiss Meditec Invests in Sales Expansion in Spain
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Acquisition of the surgical ophthalmology business assets of IMEX.
Single source comprehensive ophthalmology solutions portfolio.
JENA, Germany, 21 September 2011
Medical technology provider Carl Zeiss Meditec AG announced today its intention
to acquire the intraocular lens (IOLs) and ophthalmic viscoelastic devices
(OVDs) business of IMEX, Spain, to strengthen its sales, service and support
network in Spain. This is the objective of an asset purchase agreement signed by
both parties this evening in Vienna, Austria. Until now, IMEX has been the
exclusive partner of Carl Zeiss Meditec for its IOL & OVD business on the
Iberian peninsula. The transaction is expected to close by the end of 2011.
Carl Zeiss Meditec's growth strategy is to provide comprehensive product
solutions and excellent services to its customers. "Merging the sales forces of
IMEX and Carl Zeiss Meditec in Spain enables us to offer diagnostic and surgical
equipment, as well as the IOLs and OVDs for surgical ophthalmology procedures,
to our Iberian customers from a single source," explains Dr. Ludwin Monz,
President and CEO of Carl Zeiss Meditec AG. With the joint sales forces, Carl
Zeiss Meditec will be able to establish a very strong, competitive team of
ophthalmic experts in the market. Carl Zeiss Meditec will maintain the
outstanding level of service and support both organizations are known for. Dr.
Monz continues: "This approach will result in less complexity for customers as
they will need to deal with only one partner." In addition, Carl Zeiss Meditec
expects to improve its business performance through the replacement of the
indirect sales channel.
Spain has always been an important market for Carl Zeiss Meditec, especially for
the surgical ophthalmology business that was very successfully developed and
expanded to Portugal by IMEX in recent years. With this acquisition, Carl Zeiss
Meditec is strengthening its business, particularly in Spain, and systematically
investing in its sales and service organization. "This step will enhance our
market penetration and support future growth," concludes Dr. Ludwin Monz.
Contact for the press
Petra Rettenmaier, Director Corporate Communications, Carl Zeiss Meditec AG,
Phone: +49 36 41 220-331, Email:press(at)meditec.zeiss.com
Patrick Kofler, Director Investor Relations, Carl Zeiss Meditec AG,
Phone: +49 36 41 220-106, Email:investors(at)meditec.zeiss.com
Brief profile Carl Zeiss Meditec AG
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on TecDAX of the
German stock exchange, is one of the worlds leading medical technology
suppliers. The company supplies innovative technologies and application-oriented
solutions designed to help doctors improve the quality of live of their
patients. It provides complete packages of solutions for the diagnosis and
treatment of eye diseases - including implants and consumable materials. The
company creates innovative visualisation solutions in the field of microsurgery.
Carl Zeiss Meditecs medical technology portfolio is rounded off by promising
future technologies such as intraoperative radiation therapy. In the 2009/2010
(30 September) financial year, the around 2,200 employees generated revenue of
EUR 676 million.
Brief profile IMEX
IMEX was founded in Valencia, Spain, in 1995 and was dedicated to importing and
distributing intraocular lenses (IOL) for ophthalmic surgery in the beginning.
It is owned by Jose Maria Gimeno, Francisco Catalán and Francisco Sanchis. In
the years that followed, the company expanded and diversified its businesses to
other healthcare specialties like hospital engineering and urology. Today, 95
employees work in the business areas ophthalmology, hospital engineering,
urology and cardiology. In addition, IMEX has specialized departments that
provide outsourcing services to all the business divisions, like administration,
logistics, technical support, marketing and communications and customer service.
IMEX is based in Valencia with activities in sales and services in Spain and
Portugal. In the field of surgical ophthalmology, the company has extensive
experience and was the exclusive sales channel of Carl Zeiss Meditec on the
Iberian peninsula for its intraocular lens and ophthalmic viscoelastic devices
(OVD) business.
--- End of Message ---
Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany
WKN: 531370;ISIN: DE0005313704;Index:Prime All Share,TECH All Share,TecDAX;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Carl Zeiss Meditec AG via Thomson Reuters ONE
[HUG#1548722]
Unternehmensinformation / Kurzprofil:
Datum: 21.09.2011 - 19:23 Uhr
Sprache: Deutsch
News-ID 68360
Anzahl Zeichen: 6121
contact information:
Town:
Jena
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 313 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Carl Zeiss Meditec Invests in Sales Expansion in Spain"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
